Table 1. Characteristics of patients who received intravenous/peritumoral injection of ICG.
| Characteristic | Intravenous injection of ICG, N (%) | Peritumoral injection of ICG, N (%) |
|---|---|---|
| Number of patients | 13 | 16 |
| Gender, male | 6 (46.2) | 11 (68.8) |
| Age (year): average (range) | 65.1 [50–71] | 65.7 [54–78] |
| Primary tumor site | ||
| Tongue | 5 (38.5) | 9 (56.3) |
| Buccal mucosa | 6 (46.2) | 4 (25) |
| Palatal mucosa | 1 (7.7) | 1 (6.3) |
| Lower lip | 1 (7.7) | |
| Mandible | 1 (6.3) | |
| Pharynx | 1 (6.3) | |
| Clinical T-stage | ||
| T1 | 1 | 1 |
| T2 | 8 | 9 |
| T3 | 0 | 5 |
| T4 | 4 | 1 |
| Pathological N-stage | ||
| N0 | 9 (69.2) | 13 (81.3) |
| N1 | 3 (23.1) | 1 (6.3) |
| N2 | 1 (7.7) | 2 (12.5) |
| Surgical procedure | ||
| Unilateral neck dissection | 12 (92.3) | 15 (93.8) |
| Bilateral neck dissection | 1 (7.7) | 1 (6.2) |
ICG, indocyanine green.